PulseFlow Ltd. of Aylesbury at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

PulseFlow Ltd.

Midshires House, Smeaton Close, HP19 8HL Aylesbury
United Kingdom of Great Britain and Northern Ireland

This company is co-exhibitor of
ABHI Association of British HealthTech Industries

Hall map

MEDICA 2018 hall map (Hall 16): stand G24-4

Fairground map

MEDICA 2018 fairground map: Hall 16

Contact

Daniel Blackman

Phone
+447809144960

Email
daniel.blackman@pulse-flow.net

Annie Penn

Press Officer

Our range of products

Product categories

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.05  Compression therapy equipment

Compression therapy equipment

Our products

Product category: Compression therapy equipment

PulseflowDF

This innovative Class II medical device features a biomechanically active but unobtrusive design and state-of-the-art construction materials to simultaneously increase blood flow, offload the wound and protect the foot from further injury. Built-in monitoring software ensures accurate treatment data capture and optimal patient engagement with treatment.

PulseFlowDF utilises cutting-edge wearable technology to combine two proven treatment strategies - offloading and intermittent pneumatic compression.

Worn during waking hours, the lightweight shin unit is inconspicuous under clothing, minimising the social stigma of treatment often associated with other treatment modalities such as removable cast walkers. In contrast to total contact cast therapy, the entire PulseFlowDF device is removable to enable patients to undertake the essential activities of daily living and to minimise the risk of contralateral tissue damage during sleep.

More Less

Company news

Date

Topic

Download

Nov 12, 2018

PulseFlow Announces strategic partnership with Kir-Fix

Last week COO Dan Blackman was in Helsinki where he shared the platform with Henri Isojärvi as PulseFlow announced their strategic partnership with Kir-Fix to supply the PulseFlow wearable technology across Finland. 
 
Kir-Fix was established in Helsinki in 1992.  They supply hospitals, health centers, private clinicians and importantly directly to the patients.  They share the same goals as PulseFlow aiming to get their patients ambulant as quickly and safely as possible so that they can return to as normal a life as possible. Like PulseFlow, they invest a great deal in research and they assess products with Finnish specialists in healthcare.
 
Dan said of the relationship…” The strategic fit between PulseFlow and Kir-Fix is as close at one can imagine.  We both want the best for our patients and we both work closely with our clinical colleagues to achieve the best outcomes for them.  Kir-Fix have seen the products and recognised the benefits of our wearable technology.  They want to bring those benefits to their customers as quickly as possible and we are delighted to be working with them to achieve that”.
 
The Nordic Diabetic Foot Symposium has been running biennially since 2014.  Their aims in diabetic foot care align closely with PulseFlow’s, actively promoting and supporting the implementation of best practice in the treatment of diabetic foot care across the Nordic countries.

More Less

Oct 19, 2018

Evidence for Excellence

'What evidence is there to support our current practice?'

The Vascular Society for Great Britain and Ireland asked the above question at their 2018 conference theme 'Evidence for Excellence'.

As we gather insight and data on clinical trials currently using PulseFlow Technologies for a non invasive post operative aid to healing, we are continuing our mission to reach out and connect with Vascular Surgeons, Nurses and Scientists interested in wearable technology.

Daniel Blackman will be at MEDICA offering a full device demonstration to help teams understand exactly how the PulseFlowDF surge increases blood flow using intermittent plantar compression.

Professor Alexander M. Seifalian - Division of Surgery and Interventional Science, University College London says, "PulseFlowDF produced statistically significant increases in both oxygenation and flow of venous blood from the foot”.

Want to know more... jump straight to the page showing PFDF results NIRS Measurements and contact us on the number at the top of this page.

More Less

About us

Company details

Founded in 2010, PulseFlow Technologies (PFT) is a rapidly-growing, UK-based medical device company.

Dedicated to improving the quality of life of patients throughout the world and partnering with healthcare professionals to develop cost-effective solutions to unmet medical needs, PFT has worked with clinical experts across the world to develop PulseFlowDF with the aim of saving countless people with diabetes from undergoing lower extremity amputation.

More Less